openPR Logo
Press release

Rising Infectious Disease Prevalence Fuels Growth In The Hyperimmune Globulins Market Driver: A Crucial Influence on the Hyperimmune Globulins Market's Transformation in 2025

03-20-2025 06:07 AM CET | Health & Medicine

Press release from: The Business Research Company

Hyperimmune Globulins Market Share

Hyperimmune Globulins Market Share

Which drivers are expected to have the greatest impact on the over the hyperimmune globulins market's growth?
The rising prevalence of infectious diseases is expected to accelerate the growth of the hyperimmune globulin market. Infectious diseases are caused by pathogens like viruses, bacteria, and fungi, and their increasing prevalence is linked to factors such as antimicrobial resistance and climate change. Hyperimmune globulins provide passive immunity by delivering concentrated antibodies against specific pathogens. For example, the CDC reported that chronic hepatitis B cases in the U.S. rose by 17% from 2021 to 2022. As the incidence of infectious diseases rises, so does the demand for hyperimmune globulins.

Get Your Hyperimmune Globulins Market Report Here:
https://www.thebusinessresearchcompany.com/report/hyperimmune-globulins-global-market-report

What is the future CAGR of the hyperimmune globulins market, and how will it impact industry expansion?
The hyperimmune globulins market is projected to rise from $1.91 billion in 2024 to $2.06 billion in 2025 at a CAGR of 7.8%, supported by increased government support and rising healthcare expenditures.

The hyperimmune globulins market is projected to grow to $2.76 billion by 2029 at a CAGR of 7.6%. Increasing prevalence of infectious diseases, rising immunoglobulin demand, and growing awareness of hyperimmune globulins are key drivers. Trends include advanced plasma-derived therapies, innovation in manufacturing, passive immunity treatments, and higher R&D investments.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16448&type=smp

Which key market segments comprise the hyperimmune globulins market and drive its revenue growth?
The hyperimmune globulins market covered in this report is segmented -

1) By Type: Hepatitis B Hyperimmune Globulin, Rabies Hyperimmune Globulin, Tetanus Hyperimmune Globulin, Cytomegalovirus (CMV) Hyperimmune Globulin, Varicella-Zoster Virus (VZV) Hyperimmune Globulin, Respiratory Syncytial Virus (RSV) Hyperimmune Globulin, Other Types
2) By Route Of Administration: Intramuscular, Intravenous
3) By Application: Government Institution, Private Sector, Other Applications

Subsegments:
1) By Hepatitis B Hyperimmune Globulin: Intramuscular Hepatitis B Hyperimmune Globulin, Intravenous Hepatitis B Hyperimmune Globulin
2) By Rabies Hyperimmune Globulin: Rabies Immune Globulin (Human), Rabies Immune Globulin (Equine)
3) By Tetanus Hyperimmune Globulin: Tetanus Immune Globulin (Human), Tetanus Immune Globulin (Equine)
4) By Cytomegalovirus (Cmv) Hyperimmune Globulin: Cmv Immune Globulin For Organ Transplantation, Cmv Immune Globulin For Neonatal Infection
5) By Varicella-Zoster Virus (Vzv) Hyperimmune Globulin: Vzv Immune Globulin For Post-Exposure Prophylaxis, Vzv Immune Globulin For Immunocompromised Patients
6) By Respiratory Syncytial Virus (Rsv) Hyperimmune Globulin: Rsv Immune Globulin For Infants And Children, Rsv Immune Globulin For Adults With Respiratory Conditions
7) By Other Types: Diphtheria Hyperimmune Globulin, Botulism Hyperimmune Globulin, Other Specialized Hyperimmune Globulins

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16448

What regions are at the forefront of hyperimmune globulins market expansion?
North America was the largest region in the hyperimmune globulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperimmune globulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the hyperimmune globulins market?
Major companies operating in the hyperimmune globulins market are F. Hoffmann-La Roche AG, Bayer AG, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Ltd., Fresenius Kabi AG, Grifols SA, Octapharma AG, Shanghai RAAS Blood Products Co. Ltd., Emergent BioSolutions Inc., Kedrion Biopharma Inc., LFB SA, Hualan Biological Engineering Inc., FFF Enterprises Inc., Taibang Biologic Group, Bio Products Laboratory (BPL) Ltd., ADMA Biologics, Cangene Corporation, Kamada Ltd., Saol Therapeutics Inc., Omrix Biopharmaceuticals Ltd., Shire, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., BioCare Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=16448&type=smp

What Is Covered In The Hyperimmune Globulins Global Market Report?

•Market Size Forecast: Examine the hyperimmune globulins market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the hyperimmune globulins market for a structured understanding.
•Key Players Overview: Analyze major players in the hyperimmune globulins market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the hyperimmune globulins market.
•Segment Contributions: Evaluate how different segments drive overall growth in the hyperimmune globulins market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the hyperimmune globulins market.
•Industry Challenges: Identify potential risks and obstacles affecting the hyperimmune globulins market.
•Competitive Landscape: Review strategic developments in the hyperimmune globulins market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Infectious Disease Prevalence Fuels Growth In The Hyperimmune Globulins Market Driver: A Crucial Influence on the Hyperimmune Globulins Market's Transformation in 2025 here

News-ID: 3925716 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Globulin

Global Rho(D) Immune Globulin Market Imapct of AI and Automation
Rho(D) Immune Globulin Market Impact of AI and Automation The Rho(D) immune globulin market experienced notable growth in 2022, with its market size valued at approximately $3.4 billion. The compound annual growth rate (CAGR) during this period was around 5.2%, reflecting a steady increase in demand for this critical immunoglobulin used in preventing Rh incompatibility during pregnancy. The market's expansion is driven by heightened awareness of Rh disease, increasing prevalence of
Gamma Globulin Market 2030 Global Share, Key Country Analysis and Forecasts
Global Gamma Globulin Market Report 2023 is a professional and in-depth survey on the current state of the StandardDrywall Cleanrooms Industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The StandardDrywall Cleanrooms Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00021167?utm_source=OpenPR&utm_medium=10791 Key Players Analysis: Grifols, S.A. Baxter Octapharma AG Biotest AG Kedrion S.p.A ADMA
Anthrax Immune Globulin Market Analysis By Top Keyplayers - Emergent Biosolution …
The "Anthrax Immune Globulin Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Anthrax Immune Globulin Market, 2024-2031 Verified Market Research's most recent report, "Anthrax Immune Globulin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides
A Comprehensive Analysis of the Global Rabies Immune Globulin Market
𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: Welcome to our comprehensive exploration of the Global Rabies Immune Globulin Market. In this blog, we delve into the market dynamics, trends, and COVID-19 impact analysis to provide valuable insights for stakeholders, investors, and enthusiasts alike. 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰: The global rabies immune globulin market has witnessed significant growth and evolution over the years, driven by advancements in technology, rising awareness about rabies prevention, and increased investments in healthcare infrastructure. The market is
Gamma Globulin Market Size, Players, Revenue Analysis 2023-2030
Gamma Globulin Market Overview 2023: The Gamma Globulin Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the Gamma Globulin market. This report explores all the key factors affecting the growth of the Gamma Globulin
Global Gamma Globulin Market Research Report
This report studies the global Gamma Globulin market status and forecast, categorizes the global Gamma Globulin market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Grifols Baxter Octapharma Biotest Kedrion Geographically, this report studies the top producers and consumers, focuses on product